Neuropeptide Y and somatostatin inhibit insulin secretion through different mechanisms

American Journal of Physiology - Endocrinology and Metabolism

Volumn 304, Issue 2, 2013, Pages

  Schwetz, Tara A ^a   Ustione, Alessandro ^a   Piston, David W ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

G protein coupled receptor; Subunit

Indexed keywords

CALCIUM; ENZYME INHIBITOR; GALLEIN; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; NEUROPEPTIDE Y; SOMATOSTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL METABOLISM; CONTROLLED STUDY; DRUG MECHANISM; GLUCOSE METABOLISM; INSULIN RELEASE; METABOLIC INHIBITION; MOUSE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL;

EID: 84872376591     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00374.2012     Document Type: Article

References (53)

1. Aslanidi OV, Mornev OA, Skyggebjerg O, Arkhammar P, Thastrup O, Sorensen MP, Christiansen PL, Conradsen K, Scott AC. Excitation wave propagation as a possible mechanism for signal transmission in pancreatic islets of Langerhans. Biophys J 80: 1195-1209, 2001.
2. Bennett BD, Jetton TL, Ying GT, Magnuson MA, Piston DW. Quantitative subcellular imaging of glucose metabolism within intact pancreatic islets. J Biol Chem 271: 3647-3651, 1996.
3. Benninger RKP, Head WS, Zhang M, Satin LS, Piston DW. Gap junctions and other mechanisms of cell-cell communication regulate basal insulin secretion in the pancreatic islet. J Physiol 589: 5453-5466, 2011.
4. Benninger RKP, Zhang M, Head WS, Satin LS, Piston DW. Gap junction coupling and calcium waves in the pancreatic islet. Biophys J 95: 5048-5061, 2008.
5. 2+. Am J Physiol Endocrinol Metab 274: E796-E800, 1998.
6. 2+ in pancreaticislets correspond to pulsatile insulin release. Am J Physiol Endocrinol Metab 268: E282-E287, 1995.
7. Bertram R, Sherman A, Satin LS. Metabolic and electrical oscillations: partners in controlling pulsatile insulin secretion. Am J Physiol Endocrinol Metab 293: E890-E900, 2007.
8. Brazeau P, Guillemi. R. Somatostatin-newcomer from hypothalamus. N Engl J Med 290: 963-964, 1974.
9. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemi, R. Hypothalamic polypeptide that inhibits secretion of immunoreactive pituitary growth-hormone. Science 179: 77-79, 1973.
10. Bryant SM, Hart G. Effects of neuropeptide Y on L-type calcium current in guinea-pig ventricular myocytes. Br J Pharmacol 118: 1455-1460, 1996.
11. Cho YR, Kim CW. Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation. Biochem Biophys Res Commun 314: 773-780, 2004.
12. Claro A, Grill V, Efendic S, Luft R. Studies on mechanisms of somatostatin action on insulin release. 4. Effect of somatostatin on cyclic-AMP levels and phosphodiesterase activity in isolated rat pancreatic-islets. Acta Endocrinol 85: 379-388, 1977.
13. Daunt M, Dale O, Smith PA. Somatostatin inhibits oxidative respiration in pancreatic beta-cells. Endocrinology 147: 1527-1535, 2006.
14. Ding WG, Fujimura M, Mori A, Tooyama I, Kimura H. Light and electron-microscopy of neuropeptide-Y containing nerves in human liver, gallbladder, and pancreas. Gastroenterology 101: 1054-1059, 1991.
15. Ford CE, Skiba NP, Bae HS, Daaka YH, Reuveny E, Shekter LR, Rosal R, Weng GZ, Yang CS, Iyengar R, Miller RJ, Jan LY, Lefkowitz RJ, Hamm HE. Molecular basis for interactions of G protein beta gamma subunits with effectors. Science 280: 1271-1274, 1998.
16. Gilman AG. G-Proteins-transducers of receptor-generated signals. Annu Rev Biochem 56: 615-649, 1987.
17. Goubaeva F, Ghosh M, Malik S, Yang J, Hinkle PM, Griendling KK, Neubig RR, Smrcka AV. Stimulation of cellular signaling and G protein subunit dissociation by G protein beta gamma subunit-binding peptides. J Biol Chem 278: 19634-19641, 2003.
18. Gromada J, Hoy M, Buschard K, Salehi A, Rorsman P. Somatostatin inhibits exocytosis in rat pancreatic alpha-cells by G(i2)-dependent activation of calcineurin and depriming of secretory granules. J Physiol 535: 519-532, 2001.
19. Hellman B, Lernmark A. Inhibition of in vitro secretion of insulin by an extract of pancreatic alpha1 cells. Endocrinology 84: 1484 1969.
20. Hoenig M, Sharp GWG. Glucose induces insulin release and a rise in cytosolic calcium-concentration in a transplantable rat insulinoma. Endocrinology 119: 2502-2507, 1986.
21. Hsu WH, Xiang HD, Rajan AS, Kunze DL, Boyd AE. Somatostatin inhibits insulin-secretion by a G-protein-mediated decrease in Ca2+ entry through voltage-dependent Ca2+ channels in the beta-cell. J Biol Chem 266: 837-843, 1991.
22. Imai Y, Patel HR, Hawkins EJ, Doliba NM, Matschinsky FM, Ahima RS. Insulin secretion is increased in pancreatic islets of neuropeptide Y-deficient mice. Endocrinology 148: 5716-5723, 2007.
23. Jamal H, Jones PM, Byrne J, Suda K, Ghatei MA, Kanse SM, Bloom SR. Peptide contents of neuropeptide-Y, vasoactive intestinal polypeptide, and beta-calcitonin gene-related peptide and their messenger ribonucleicacids after dexamethasone treatment in the isolated rat islets of Langerhans. Endocrinology 129: 3372-3380, 1991.
24. Klabunde T, Hessler G. Drug design strategies for targeting G-proteincoupled receptors. Chem Biochem 3: 929-944, 2002.
25. Lehmann DM, Seneviratne AMPB, Smrcka AV. Small molecule disruption of G protein beta gamma subunit signaling inhibits neutrophil chemotaxis and inflammation. Mol Pharmacol 73: 410-418, 2008.
26. Lin Y, Smrcka AV. Understanding molecular recognition by G protein betagamma subunits on the path to pharmacological targeting. Mol Pharmacol 80: 551-557.
27. Moller N, Jorgensen JOL. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30: 152-177, 2009.
28. Morgan DG, Kulkarni RN, Hurley JD, Wang ZL, Wang RM, Ghatei MA, Karlsen AE, Bloom SR, Smith DM. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells. Diabetologia 41: 1482-1491, 1998.
29. Myrsen U, Ahren B, Sundler F. Neuropeptide-Y is expressed in subpopulations of insulin and non-insulin islet cells in the rat after dexamethasone treatment-a combined immunocytochemical and in-situ hybridization study. Diabetes 44: A132-A132, 1995.
30. Myrsen U, Mulder H, Ahren B, Sundler F. Dexamethasone induces NPY expression in RINm5F cells: evidence for constitutive release of NPY and impaired insulin secretion. Diabetes 45: 555-555, 1996.
31. Myrsen Axcrona U, Ekblad E, Sundler F. Developmental expression of NPY, PYY and PP in the rat pancreas and their coexistence with islet hormones. Regul Pept 68: 165-175, 1997.
32. Orci L, Baetens D, Dubois MP, Rufener C. Evidence for D-cell of pancreas secreting somatostatin. Horm Metab Res 7: 400-402, 1975.
33. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 20: 157-198, 1999.
34. Patel YC, Greenwood MT, Warszynska A, Panetta R, Srikant CB. All 5 cloned human somatostatin receptors (Hsstr1-5) are functionally coupled to adenylyl-cyclase. Biochem Biophys Res Commun 198: 605-612, 1994.
35. Pettersson M, Ahren B, Lundquist I, Bottcher G, Sundler F. Neuropeptide- Y-intrapancreatic neuronal localization and effects on insulinsecretion in the mouse. Cell Tissue Res 248: 43-48, 1987.
36. Piston DW, Knobel SM. Real-time analysis of glucose metabolism by microscopy. Trends Endocrinol Metab 10: 413-417, 1999.
37. Porte D, Williams RH. Inhibition of insulin release by norepinephrine in man. Science 152: 1248-&, 1966.
38. Portela-Gomes GM, Stridsberg M, Grimelius L, Oberg K, Janson ET. Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas. Appl Immunohistochem Mol Morphol 8: 126-132, 2000.
39. Renstrom E, Ding WG, Bokvist K, Rorsman P. Neurotransmitterinduced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin. Neuron 17: 513-522, 1996.
40. Rocheleau JV, Head WS, Piston DW. Quantitative NAD(P)H/flavoprotein autofluorescence imaging reveals metabolic mechanisms of pancreatic islet pyruvate response. J Biol Chem 279: 31780-31787, 2004.
41. Scharp DW, Kemp CB, Knight MJ, Ballinge WF, Lacy PE. Use of Ficoll in preparation of viable islets of Langerhans from rat pancreas. Transplantation 16: 686-689, 1973.
42. Silva AP, Carvalho AP, Carvalho CM, Malva JO. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology 44: 282-292, 2003.
43. Skoglund G, Gross R, Ahren B, Loubatieresmariani MM. Different mechanisms are involved in neuropeptide Y-induced pancreatic vasoconstriction and inhibition of insulin-secretion. Eur J Pharmacol 236: 69-74, 1993.
44. 2+)-channels in murine pancreatic beta-cells are inhibited by an exclusive coupling with somatostatin receptor subtype 1. Endocrinology 150: 741-748, 2009.
45. Stanley BG, Anderson KC, Grayson MH, Leibowitz SF. Repeated hypothalamic-stimulation with neuropeptide-Y increases daily carbohydrate and fat intake and body-weight gain in female rats. Physiol Behav 46: 173-177, 1989.
46. Stefan Y, Meda P, Neufeld M, Orci L. Stimulation of insulin-secretion reveals heterogeneity of pancreatic B-cells in vivo. J Clin Invest 80: 175-183, 1987.
47. Strowski MZ, Parmar RM, Blake AD, Schaeffer JM. Somatostatin inhibits insulin and glucagon secretion via two receptor subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 141: 111-117, 2000.
48. Whim MD. Pancreatic beta cells synthesize neuropeptide Y and can rapidly release peptide co-transmitters. PLos One 6: 2011.
49. Winzell MS, Ahren B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol Therapeut 116: 437-448, 2007.
50. Wollheim CB, Sharp GWG. Regulation of insulin release by calcium. Physiol Rev 61: 914-973, 1981.
51. Xu T, Ashery U, Burgoyne RD, Neher E. Early requirement for alpha-SNAP and NSF in the secretory cascade in chromaffin cells. EMBO J 18: 3293-3304, 1999.
52. Xu T, Binz T, Niemann H, Neher E. Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity. Nat Neurosci 1: 192-200, 1998.
53. Zhao Y, Fang QH, Straub SG, Lindau M, Sharp GWG. Noradrenaline inhibits exocytosis via the G protein beta gamma subunit and refilling of the readily releasable granule pool via the alpha(i1/2) subunit. J Physiol 588: 3485-3498, 2010.